Skip to main content
Figure 2 | Breast Cancer Research

Figure 2

From: A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study

Figure 2

ER-beta (ER-β), p53, Ki-67 and Bcl2 distribution within BC molecular subtypes. Estrogen receptor-beta (ER-β) evenly distributes (55% to 56%, P = 0.99) across the four molecular subtypes (a), whereas the percentages of p53 (b) and Ki67+ (c) tumors significantly increased (P < 0.0001) and the percentage of Bcl2 significantly decreased (P < 0.0001) moving from the luminal A (LA) phenotype to luminal B (LB), triple-negative (TN), and HER2 (HS) (d).

Back to article page